Contact
white printer paper on black table

Covering Redenlab? Start here

Writing a story about Redenlab or one of our research pipeline hightlights?

Redenlab's Overview

Communication is a core human function, and measuring its decline through objective biomarkers is critical to understanding overall disease severity and functional quality of life, which is often missed by conventional assessments

Redenlab is a neuroscience clinical outcome assessment technology company founded in 2017. We specialise in the development and application of speech, language, swallowing, and audio biomarkers for clinical trials and healthcare research. Our proven digital speech platform delivers objective measurements of communication and other quality of life abilities, supporting the evaluation of treatment efficacy and ongoing patient health monitoring. Our team, which includes trained clinicians and engineers, ensures that all product development is grounded in robust science and clinical utility. Over a decade, we have partnered with a diverse range of clients, including leading pharmaceutical and biotech companies, medical clinics, and academic research institutions, solidifying our reputation as a trusted innovator in the field.

Global reach:
Used in 25+ countries, across 350+ sites

Data scale: Over 200,000 recordings analysed

Scientific rigour:
247 publications

  • What we do

    Objective speech measurement for clinical research

    We develop digital tools that analyse voice and speech to help researchers understand how diseases impact people.

    We help medical researchers:

    • Detect early signs of diseases
    • Measure if new treatments are working effectively
    • Gather reliable data quickly and easily for clinical trials
  • How it works

    • A patient speaks into a smartphone, tablet, or computer
    • Our software captures and securely analyses the recording
    • Our clinical team ensures data quality and provides scientifically rigorous reporting
  • Why it matters

    Speech is a core human function and a highly sensitive, noninvasive indicator of changes in the brain and body.

    Accurate speech measurement helps researchers and clinicians to:

    • detect subtle, early signs of change traditional methods may miss
    • measure treatment effects objectively
    • support streamlined regulatory approval pathways
    • reduce subjective measurement burden on patients and clinicians
    •  
  • Why Redenlab is different

    • Clinically driven, not just a tech platform: All tasks, endpoints and data oversight are designed and managed by our in house team of clinician and scientists
    • Proven science: We leverage the largest scale of clinically validated speech data in the field
    • End to end approach: From data capture to quality assurance to reporting

Trusted by

      Media contact

      For media enquiries, interview requests with our executives or scientific experts, or expert commentary, please contact:

      Gloria Macan
      Chief Marketing Officer
      Gmacan@redenlab.com